Tobira Therapeutics, Inc. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d8d6498f-4c05-4aac-a501-7d53306f455b/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-49.6M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-013992 |
| FY 2014 | $-24.1M | 2014-01-01 – 2014-12-31 | evidence 0001564590-16-013992 |
| FY 2013 | $-160.8M | 2001-12-01 – 2014-03-31 | evidence 0001193125-14-197159 |
| FY 2012 | $-13.1M | 2012-01-01 – 2012-12-31 | evidence 0001193125-14-095713 |
| FY 2011 | $-97.5M | 2001-12-20 – 2011-12-31 | evidence 0001193125-14-095713 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).